The European Paediatric Formulary platform continues to evolve, boosting its usability and reach across Europe. In a significant step forward, all texts published in the formulary are now available in French. This not only broadens access for French-speaking healthcare professionals, but brings the platform into conformity with the Council of Europe’s Language Policy and the principle of parity between the two official languages, English and French.
In addition, to enhance navigation and improve searchability, the platform now features new filters for active substance and pharmaceutical form, allowing users to locate relevant monographs more efficiently and supporting more targeted searches. The table of contents has also been redesigned and now includes two new entries that clearly separate general texts from monographs, streamlining the user experience.
The European Paediatric Formulary provides free access to extemporaneous formulation monographs for paediatric medicines, especially in cases where no appropriately licensed medicines are available. By compiling best practices from national and regional formularies across Europe, the platform supports healthcare providers in delivering safe and effective treatments for children.
See also: